What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer?

about

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†The lymph node microenvironment and its role in the progression of metastatic cancer.The Lymphatic System in Disease Processes and Cancer Progression

P2860

Q30317067-43411EAB-A8BB-42AC-9E7F-C002DDDA1255 Q35417958-D503FDDC-3A76-4C48-8629-5459E7E078F0 Q37099065-3075C8E8-96C7-47B7-BC40-3EBB4F27DCB4

P2860

What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer?

Item

http://www.wikidata.org/entity/Q36738511

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

What is the burden of axillary ...... ocally advanced breast cancer?

@ast

What is the burden of axillary ...... ocally advanced breast cancer?

@en

type

Item

label

What is the burden of axillary ...... ocally advanced breast cancer?

@ast

What is the burden of axillary ...... ocally advanced breast cancer?

@en

prefLabel

What is the burden of axillary ...... ocally advanced breast cancer?

@ast

What is the burden of axillary ...... ocally advanced breast cancer?

@en

P1476

What is the burden of axillary ...... ocally advanced breast cancer?

@en

P2093

A Shaheta

http://www.w3.org/2001/XMLSchema#string

C Cox

http://www.w3.org/2001/XMLSchema#string

F C Wright

http://www.w3.org/2001/XMLSchema#string

S Nofech-Mozes

http://www.w3.org/2001/XMLSchema#string

P2860

Sentinel lymph node biopsy after neoadjuvant systemic therapy.

Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.

Axillary staging in the neoadjuvant setting.

Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging.

Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study.

Axillary sentinel node biopsy after neoadjuvant chemotherapy.

The medical legal implications of following mammographic breast masses.

Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.

The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer.

P304

111-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3747/CO.20.1214

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claire M B Holloway

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236115107

http://www.w3.org/2001/XMLSchema#string

P698

23559874

http://www.w3.org/2001/XMLSchema#string

P932

3615853

http://www.w3.org/2001/XMLSchema#string

What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer?

about

P2860

P2860

What is the burden of axillary disease after neoadjuvant therapy in women with locally advanced breast cancer?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932